These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10776070)

  • 21. Treating muscular dystrophy by stimulating intrinsic repair.
    Wang YX; Bentzinger CF; Rudnicki MA
    Regen Med; 2013 May; 8(3):237-40. PubMed ID: 23627818
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of body composition in muscular dystrophy by MRI and stereology.
    Gong QY; Phoenix J; Kemp GJ; García-Fiñana M; Frostick SP; Brodie DA; Edwards RH; Whitehouse GH; Roberts N
    J Magn Reson Imaging; 2000 Sep; 12(3):467-75. PubMed ID: 10992315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy.
    Punkt K; Schering S; Löffler S; Minin EA; Samoilova VE; Hasselblatt M; Paulus W; Müller-Werdan U; Demus U; Koehler G; Boecker W; Buchwalow IB
    Biochem Biophys Res Commun; 2006 Sep; 348(1):259-64. PubMed ID: 16876119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveolin-3 helps build muscles.
    Marx J
    Science; 2001 Nov; 294(5548):1864. PubMed ID: 11729301
    [No Abstract]   [Full Text] [Related]  

  • 26. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
    Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
    Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of a novel caveolin-3 mutation in a large German family.
    Fischer D; Schroers A; Blümcke I; Urbach H; Zerres K; Mortier W; Vorgerd M; Schröder R
    Ann Neurol; 2003 Feb; 53(2):233-41. PubMed ID: 12557291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limb-girdle muscular dystrophies.
    Piccolo F; Moore SA; Mathews KD; Campbell KP
    Adv Neurol; 2002; 88():273-91. PubMed ID: 11908231
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetically confirmed patients with merosin-deficient congenital muscular dystrophy in China.
    Yuan J; Takashima H; Higuchi I; Arimura K; Li N; Zhao Z; Shen H; Hu J
    Neuropediatrics; 2008 Oct; 39(5):264-7. PubMed ID: 19294599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.
    Leung DG
    Muscle Nerve; 2019 Oct; 60(4):347-360. PubMed ID: 31026060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distal muscular dystrophy of the Miyoshi type.
    Yildiz H; Emre U; Coskun O; Ergün U; Atasoy HT; Inan LE
    Clin Neuropathol; 2003; 22(4):204-8. PubMed ID: 12908758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shank sign in myotonic dystrophy type-1 (DM-1).
    Pradhan S
    J Clin Neurosci; 2007 Jan; 14(1):27-32. PubMed ID: 17092719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy.
    Sewry CA
    J Clin Pathol; 2002 Aug; 55(8):639; author reply 639. PubMed ID: 12147670
    [No Abstract]   [Full Text] [Related]  

  • 37. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrous-adipose replacement in skeletal muscle biopsy.
    Mora M
    Eur Heart J; 1989 Sep; 10 Suppl D():103-4. PubMed ID: 2806293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special Issue--Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases.
    Phylactou LA
    Molecules; 2015 Jul; 20(7):12944-5. PubMed ID: 26791289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes.
    Loughran T; Higgins DM; McCallum M; Coombs A; Straub V; Hollingsworth KG
    Radiology; 2015 May; 275(2):570-8. PubMed ID: 25575118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.